MedPath

ITALFARMACO SPA

ITALFARMACO SPA logo
🇮🇹Italy
Ownership
Subsidiary
Established
1938-01-01
Employees
5K
Market Cap
-
Website
http://www.italfarmaco.com

Clinical Trials

8

Active:8
Completed:0

Trial Phases

1 Phases

Phase 1:8

Drug Approvals

3

FDA:3

Drug Approvals

DUVYZAT

Approval Date
Mar 29, 2024
FDA

Enoxaparin Sodium

Approval Date
Nov 5, 2022
FDA

fondaparinux sodium

Approval Date
Oct 30, 2020
FDA

Clinical Trials

Distribution across different clinical trial phases (8 trials with phase data)• Click on a phase to view related trials

Phase 1
8 (100.0%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.